Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 20OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Tobacco Use Cessation 1Recurrence 1Rectal Diseases 1Pancreatic Cancer Liver Metastases 1Ovarian Neoplasms 1Ototoxicity 1Neoplasms, Second Primary 1Neoplasms by Site 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Intestinal Neoplasms 1Intestinal Diseases 1Hodgkin Disease 1Hearing Loss 1HER2 Positive Metastatic Breast Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1

Interventions

Cisplatin 5Fluorouracil 4Capecitabine 4tislelizumab 2Radiation 2Gemcitabine 2toripalimab 1temoporfin 1nimotuzumab 1fludarabine 1Taxes 1Radiotherapy, Intensity-Modulated 1Maintenance Chemotherapy 1Drug Therapy 1Cyclophosphamide 1Cell Count 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Nasopharyngeal Carcinoma × Drug Therapy × Clear all
NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase 2 Unknown
70 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡